Back to Journals » OncoTargets and Therapy » Volume 13

GRHL2 Upregulation Predicts a Poor Prognosis and Promotes the Resistance of Serous Ovarian Cancer to Cisplatin

Total article views   HTML views PDF downloads Totals
4,743 Dovepress* 4,355+ 769 5,124
PubMed Central* 388 91 479
Totals 4,743 860 5,603
*Since 30 June 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar